BCL2 and leukemia: Hence, our results indicate that cellular differentiation is a targetable state in pedAML and suggest that selective chemotherapy may improve outcome in more differentiated leukemias and that targeted treatments with BCL2 or HDAC inhibition may improve outcome in more HSC-like leukemias.